FindTrial
Sign In

The study on inhibition of ocular surface and meibomian gland inflammation by periorbital intense pulsed light irradiation

The study on inhibition of ocular surface and meibomian gland inflammation by periorbital intense pulsed light irradiation

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037228
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye disease

Interventions

Group 1:Intense pulsed light treatment
Group 2:Drug
Group 3:Non-intervention control group

Sponsors

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with moderate to severe meibomian gland dysfunction dry eye disease. 2. Aged 18-70 years.

Exclusion criteria

Exclusion criteria: 1. Have recently taken drugs such as hormones or antibiotics; 2. Those who have recently used photosensitive drugs; 3. Pregnancy.

Design outcomes

Primary

MeasureTime frame
Human Cytokine;—

Countries

China

Contacts

Public ContactDan Li

Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong

13729262500@139.com+86 13729262500

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026